https://www.selleckchem.com/pr....oducts/i-bet-762.htm
First studies on stem cell therapy for severe dry eye in Sjögren syndrome showed asafe and effective application of mesenchymal stem cells by injection into the lacrimal gland. Due to the limitations of currently available replacement tissues, there is aclinical need for the development of new materials for adnexa oculi reconstruction. Constructs grown in vitro with allogeneic and/or genetically engineered cells are slowly making their way into clinical practice. The efficacy and mode of action of stem cells in severe dry eye are subj